Gut-derived lipopolysaccharide augments adipose macrophage accumulation but is not essential for impaired glucose or insulin tolerance in mice.
about
Assessing the human gut microbiota in metabolic diseasesObesity: An Immunometabolic PerspectiveImmunological contributions to adipose tissue homeostasisLPS-Enhanced Glucose-Stimulated Insulin Secretion Is Normalized by ResveratrolAdipose tissue macrophage in immune regulation of metabolism.Metagenome and metabolism: the tissue microbiota hypothesis.Gut microbioma population: an indicator really sensible to any change in age, diet, metabolic syndrome, and life-style.The intricate association between gut microbiota and development of type 1, type 2 and type 3 diabetes.Microbial translocation and cardiometabolic risk factors in HIV infection.Obesity and microbiota: an example of an intricate relationship.Exploring the influence of the gut microbiota and probiotics on health: a symposium report.Comparison with ancestral diets suggests dense acellular carbohydrates promote an inflammatory microbiota, and may be the primary dietary cause of leptin resistance and obesityCrosstalk between Gut Microbiota and Dietary Lipids Aggravates WAT Inflammation through TLR Signaling.The gut microbiota modulates glycaemic control and serum metabolite profiles in non-obese diabetic miceModulation of gut microbiota during probiotic-mediated attenuation of metabolic syndrome in high fat diet-fed mice.Childhood obesity: a role for gut microbiota?Intestinal microbiota and faecal transplantation as treatment modality for insulin resistance and type 2 diabetes mellitus.Defective NOD2 peptidoglycan sensing promotes diet-induced inflammation, dysbiosis, and insulin resistance.Understanding the role of gut microbiome in metabolic disease risk.Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota.Understanding the Mysterious M2 Macrophage through Activation Markers and Effector Mechanisms.Adaptive Immunity and Antigen-Specific Activation in Obesity-Associated Insulin Resistance.Indigenous microbiota and Leishmaniasis.Influence of gut bacteria on development and progression of non-alcoholic fatty liver disease.Interaction between dietary lipids and gut microbiota regulates hepatic cholesterol metabolism.Investigating a holobiont: Microbiota perturbations and transkingdom networks.The gut microbiota and metabolic disease: current understanding and future perspectives.Diet-microbiota interactions as moderators of human metabolism.The gut microbiota: a key regulator of metabolic diseases.Personalized microbiome-based approaches to metabolic syndrome management and prevention.Diet-induced dysbiosis of the intestinal microbiota and the effects on immunity and disease.Host remodeling of the gut microbiome and metabolic changes during pregnancyMetagenomic Analysis of Antibiotic-Induced Changes in Gut Microbiota in a Pregnant Rat ModelMetabolic endotoxemia directly increases the proliferation of adipocyte precursors at the onset of metabolic diseases through a CD14-dependent mechanismPlasma lipopolysaccharide is closely associated with glycemic control and abdominal obesity: evidence from bariatric surgery.Akkermansia muciniphila mediates negative effects of IFNγ on glucose metabolism.Colonic luminal microbiota and bacterial metabolite composition in pregnant Huanjiang mini-pigs: effects of food composition at different times of pregnancy.Potential mediators linking gut bacteria to metabolic health: a critical view.Regulation of metabolism by the innate immune system.Parasites, microbiota and metabolic disease.
P2860
Q26860785-56CB97D9-F20A-4680-AE34-0818294F7572Q28072140-28EA6F10-E8A4-4EC1-9052-D97DD9E5B76BQ28084995-DC27328E-60B3-4E55-8A25-1E5F1148C721Q28552277-79F12863-AD6D-48C4-A4D8-66ABEEAAF181Q30241406-4C41C601-83C1-4F00-AA5E-33D25BA8A4FFQ30353335-8FF98E2B-8768-4A78-BBCA-649C725DD173Q30364423-50B27081-A561-4A0E-BB99-A6137ABA2E65Q31141977-B4BBD1CE-8207-4C4D-A91B-348CE6757698Q33713895-7271A39A-6A7F-4C5B-B869-7D7022ABD255Q33805550-D98A7D5D-F327-4E4C-A59E-0B195D701F95Q33829118-23A30B0F-E557-4E20-9CDC-F4451744367BQ34289971-C0F996AB-2B70-45A4-9579-A7D285E1B040Q34491604-9A7F7BFC-C9BC-4E49-984F-D6D3B194D1C5Q34497283-0E637C91-3843-42B1-A899-C6CCBCF75831Q34760466-40EE2393-0810-48C6-B69B-476B3F885EE3Q35015022-6EAC5562-15BF-4199-A467-ABC1EB1814FAQ35094314-E2438741-C5E6-4F93-9236-2E478825B399Q35192440-7F47A3D0-3C81-4034-A415-6B25EA680281Q35331225-DD3B1524-8C7D-4080-AA66-4D5607AA1CFDQ35671765-93A50899-71B5-468C-B0A6-B060691ADF58Q35674290-39C33EC1-983E-4FEF-ACE4-864ADF70B15CQ35753282-7A92A3D3-5B2B-460D-83DA-BAF7BB958B61Q35788474-21CEB9D1-6DC3-4E33-8541-506625CF3F94Q35790409-D4F912FA-9748-41B1-8223-3F2AC5F98855Q35897385-48124612-57C4-4052-8753-D6C9118611CEQ35958154-3F17FEDB-5C48-4EB8-B5DE-56BFF96CBA42Q35987618-4AF94147-EE5A-446E-B4E4-75CB3BD124CDQ36069065-1F407C34-18DD-4CD1-9B37-A4EEA0FA3481Q36105233-0CB05256-BDD9-4C70-82A0-4345EA5491B1Q36175953-1E7B3264-AB48-49D6-A0BA-7564B031E81CQ36250322-5BCD826A-1103-4F95-AEA9-D538EF84968BQ36421887-5ADA52B7-0966-4E15-A901-0F69A5153386Q36848257-706BD42F-1F85-4DD7-A321-A171EB1CF253Q37173378-C594C704-61AC-4488-B8A5-241E145309DBQ37278034-A1AD07ED-19AD-41BE-8463-E9141D82D387Q37421598-B3ADBD4B-9F70-462F-A566-8354CC608CF6Q37471995-E120C703-7086-4760-8913-79EF639C40ABQ37583957-522C5B56-9F87-4085-AEB5-428AA9DF6D9CQ38629225-BA892E67-8BAE-408C-8E2D-4E08D7ACA076Q38975148-2B9D07FB-5FF9-4D26-9DCF-1B4128909390
P2860
Gut-derived lipopolysaccharide augments adipose macrophage accumulation but is not essential for impaired glucose or insulin tolerance in mice.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Gut-derived lipopolysaccharide ...... or insulin tolerance in mice.
@en
Gut-derived lipopolysaccharide ...... or insulin tolerance in mice.
@nl
type
label
Gut-derived lipopolysaccharide ...... or insulin tolerance in mice.
@en
Gut-derived lipopolysaccharide ...... or insulin tolerance in mice.
@nl
prefLabel
Gut-derived lipopolysaccharide ...... or insulin tolerance in mice.
@en
Gut-derived lipopolysaccharide ...... or insulin tolerance in mice.
@nl
P2093
P2860
P921
P1433
P1476
Gut-derived lipopolysaccharide ...... or insulin tolerance in mice.
@en
P2093
Christoph Reinhardt
Christopher S Reigstad
Gunnel Östergren Lundén
Helene Kling Bäckhed
Maria Ketonen
Robert Caesar
P2860
P304
P356
10.1136/GUTJNL-2011-301689
P407
P577
2012-04-25T00:00:00Z